In this Healthed lecture, Prof Andrew Sindone will discuss the ever lower targets for LDL-C particularly in secondary prevention as well as presenting data that shows even high risk populations are failing to meet these targets. He will also discuss the latest available therapy for persistently elevated LDL-C levels that has proven benefits in terms of effectiveness, safety, accessibility and compliance.
See omnystudio.com/listener for privacy information.
